CRISPR Study Is First to Change DNA in Living Human Participants

“Researchers from the OHSU Casey Eye Institute in Portland, Oregon, have broken new ground in science, medicine, and surgery…. Known as the BRILLIANCE clinical trial, the procedure is designed to repair mutations in a particular gene that causes Leber congenital amaurosis type 10, also known as retinal dystrophy.” - Healthline

Discussion